Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women.

@article{Gambacciani1997EffectsOC,
  title={Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women.},
  author={Marco Gambacciani and Massimo Ciaponi and Barbara Cappagli and L. Piaggesi and Andrea Riccardo Genazzani},
  journal={Maturitas},
  year={1997},
  volume={28 1},
  pages={75-81}
}
OBJECTIVES To assess the pattern of biochemical markers of bone metabolism and vertebral bone mineral density in early postmenopausal women treated with combined ipriflavone and low dose conjugated estrogens. METHODS Bone biochemical markers and vertebral bone density were evaluated in a longitudinal, comparative, 2 year study conducted in postmenopausal women treated with sole calcium supplementation (500 mg/day), or with either ipriflavone (IP) at the standard dose (600 mg/day) plus the… CONTINUE READING